Position in OGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$27,080
+$15,100 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#311
of 626 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Founders Capital Management holds $23,776,064 across 8 Drug Manufacturers - General names. OGN ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,663 | $11,851,002 | |
| 2 | ABBV |
AbbVie Inc.
|
25,101 | $6,316,415 | |
| 3 | MRK |
Merck & Co., Inc.
|
38,583 | $4,957,915 | |
| 4 | PFE |
Pfizer Inc
|
13,473 | $324,429 | |
| 5 | AMGN |
Amgen Inc
|
409 | $148,107 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,500 | $86,430 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
512 | $64,686 | |
| 8 | OGN |
Organon & Co.
This page
|
2,000 | $27,080 |
All Filings in OGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,080 | 2,000 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $11,980 | 2,000 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $14,340 | 2,000 | Shares | Sole | 2026-01-15 | |
| 2023-03-31 | $2,940 | 125 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $3 | 125 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $2,925 | 125 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $5,906 | 175 | Shares | Sole | 2022-07-20 | |
| 2021-06-30 | $82,367 | 2,722 | Shares | Sole | 2021-07-15 | |
| No filing history on record for this holder in this stock. | ||||||